Find information on thousands of medical conditions and prescription drugs.

Anafranil

Clomipramine (brand-name Anafranil®) is a tricyclic antidepressant. more...

Home
Diseases
Medicines
A
8-Hour Bayer
Abacavir
Abamectin
Abarelix
Abciximab
Abelcet
Abilify
Abreva
Acamprosate
Acarbose
Accolate
Accoleit
Accupril
Accurbron
Accure
Accuretic
Accutane
Acebutolol
Aceclidine
Acepromazine
Acesulfame
Acetaminophen
Acetazolamide
Acetohexamide
Acetohexamide
Acetylcholine chloride
Acetylcysteine
Acetyldigitoxin
Aciclovir
Acihexal
Acilac
Aciphex
Acitretin
Actifed
Actigall
Actiq
Actisite
Actonel
Actos
Acular
Acyclovir
Adalat
Adapalene
Adderall
Adefovir
Adrafinil
Adriamycin
Adriamycin
Advicor
Advil
Aerobid
Aerolate
Afrinol
Aggrenox
Agomelatine
Agrylin
Airomir
Alanine
Alavert
Albendazole
Alcaine
Alclometasone
Aldomet
Aldosterone
Alesse
Aleve
Alfenta
Alfentanil
Alfuzosin
Alimta
Alkeran
Alkeran
Allegra
Allopurinol
Alora
Alosetron
Alpidem
Alprazolam
Altace
Alteplase
Alvircept sudotox
Amantadine
Amaryl
Ambien
Ambisome
Amfetamine
Amicar
Amifostine
Amikacin
Amiloride
Amineptine
Aminocaproic acid
Aminoglutethimide
Aminophenazone
Aminophylline
Amiodarone
Amisulpride
Amitraz
Amitriptyline
Amlodipine
Amobarbital
Amohexal
Amoxapine
Amoxicillin
Amoxil
Amphetamine
Amphotec
Amphotericin B
Ampicillin
Anafranil
Anagrelide
Anakinra
Anaprox
Anastrozole
Ancef
Android
Anexsia
Aniracetam
Antabuse
Antitussive
Antivert
Apidra
Apresoline
Aquaphyllin
Aquaphyllin
Aranesp
Aranesp
Arava
Arestin
Arestin
Argatroban
Argatroban
Argatroban
Argatroban
Arginine
Arginine
Aricept
Aricept
Arimidex
Arimidex
Aripiprazole
Aripiprazole
Arixtra
Arixtra
Artane
Artane
Artemether
Artemether
Artemisinin
Artemisinin
Artesunate
Artesunate
Arthrotec
Arthrotec
Asacol
Ascorbic acid
Asmalix
Aspartame
Aspartic acid
Aspirin
Astemizole
Atacand
Atarax
Atehexal
Atenolol
Ativan
Atorvastatin
Atosiban
Atovaquone
Atridox
Atropine
Atrovent
Augmentin
Aureomycin
Avandia
Avapro
Avinza
Avizafone
Avobenzone
Avodart
Axid
Axotal
Azacitidine
Azahexal
Azathioprine
Azelaic acid
Azimilide
Azithromycin
Azlocillin
Azmacort
Aztreonam
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

Indications

  • Depression with lack of energy or mild agitation
  • Obsessive Compulsive Disorders (OCD)
  • Panic attacks with or without Agoraphobia
  • Narcolepsy
  • chronic pain with or without organic disease, particular headache of the tension type
  • Enuresis (involuntary nightly urinating in sleep) in children / adolescents
  • Off label, sometimes antidepressants of this type have been found helpful in reducing relapses in cocaine addicts and to help repair cocaine-caused neurotransmitter imbalances and early brain damage. Further studies are needed for Clomipramine in this regard.

It may take 2 to 3 weeks before the full effects of this medication are noticed in all indications.

Contraindications

  • Concomitant therapy with an (irreversible) MAO-Inhibitor (e.g. Tranylcypromin, Phenelzin)
  • Acute intoxication with central depressants (alcohol, psychoactive drugs, narcotics)
  • States of confusion (caution), absolutely contraindicated in patients with coma and Delirium tremens
  • Patients with massive agitation or anxiety (give sedative drugs concomittantly)
  • Hypersensitivity/Allergy against Clomipramine or other related tricyclic compounds
  • Hypertrophy of the Prostate with urine retention (=difficulty in urinating)
  • Caution : Hypertrophy of the Prostate without urine retention
  • Preexisting closed angle glaucoma
  • Epilepsy and other conditions which lower the seizure-threshold (alcohol-withdrawal, active brain tumors)
  • Serious liver disease (elimination is decreased), if Clomipramine is given consider dose reduction
  • Serious kidney disease (elimination is decresed), if Clomipramine is given consider dose reduction
  • Severe hypotension, shock, serious cardiovascular dysfunction (postinfarctous states, heart insufficience, arrhythmias), avoid high oral doses or injections/infusions
  • Preexisting bone marrow depression (leukopenia, thrombopenia, anemia, pancytopenia), can be worsened by Clomipramine
  • Overfunction of the thyreoid gland makes the patient more sensitive to side-effects of Clomipramine. Cautious doses should be used and the overfunction should be treated.
  • Caution should be exerted when treating pediatric patients under 18 yrs. of age

Pharmacology

Clomipramine is the 3-chloro derivative of Imipramine. Clomipramine is a strong, but not completely selective Serotonic-Reuptake-Inhibitor (SRI), as the active main metabolite Desmethyclomipramine acts preferably as inhibitor of Noradrenaline-Reuptake. Other hydroxy-metabolites are also active. Alpha-1-Receptor blockage and beta-down-regulation as well as postsynaptic antagonism on H1 (histaminergic)-receptors have been noted. A blockade of Sodium-channels and NDMA-receptors might, as with other tricyclics, account for its effect in chronic pain, particular of the neuropathic type.

Read more at Wikipedia.org


[List your site here Free!]


Psychotropic drug interactions with grapefruit juice
From Perspectives in Psychiatric Care, 1/1/02 by Keltner, Norman L

Most of us have become acquainted with the cytochrome P450 (or just P450) enzyme system, which is the metabolic pathway for a significant number of psychotropic drugs. This drug-metabolizing system was once referred to as the hepatic microsomal enzyme system (Lehne, 2001), but more precise study has refined our understanding and resulted in a more descriptive designation.

The P450 enzymes are oxidase systems, and more than 40 P450 enzyme subtypes have been identified in humans (Cozza & Armstrong, 2001). Six of these enzymes are responsible for 90% of human drug oxidation: 1A2, 3A4, 2C9, 2C19, 2D6, and 2E1 (Cozza & Armstrong; Guengerich, 1997). The P450 enzymes are also responsible for many if not most of the drug-drug interactions that occur (Cozza & Armstrong). Drug-drug interactions cause serious complications to a patient's health, can be deadly, and are largely preventable.

A less common yet significant interaction occurs between drugs and certain foods. For example, mixing monoamine oxidase inhibitors (MAOIs) with foods containing tyramine can lead to a deadly hypertensive crisis; combining warfarin (Coumadin) with vitamin K-containing foods (e.g., green, leafy vegetables) promotes clotting-factor synthesis; and eating foods containing vitamin B6 while undergoing levodopa therapy results in increased metabolism of levodopa and its reduced effectiveness (Menke, 1998). Grapefruit juice also causes important food-drug interactions.

Grapefruit juice inhibits two of the six major P450 enyzmes---the 3A4 enzyme and, to a lesser extent, 1A2. The specific components of grapefruit juice thought to inhibit 3A4 are psoralen derivatives, the flavonoid derivatives naringenin and naringin, and several other substances (Fuhr, 1998; Fuhr & Kummert, 1995; Fukuda, Guo, Ohashi, Yoshikawa, & Yamazoe, 2000; Malhotra, Bailey, Paine, & Watkins, 2001). Singly, none of the constituents seems profoundly inhibitory, which suggests a complex synergy may be responsible for inhibition of 3A4 and 1A2. The enzyme 3A4 is located in the liver (about 30% of this enzyme), but the majority is found in the gut wall (Bailey, Malcolm, Arnold, & Spence, 1998; Cozza & Armstrong, 2001). More than 100 drugs are metabolized by this enzyme, so any agent that would inhibit 3A4 has the potential to elevate serum levels of those drugs. Table 1 lists some of the categories of drugs metabolized by 3A4.

Not all drugs in the categories listed in Table 1 are affected by grapefruit juice. Grapefruit juice has its inhibiting effect on gut wall-3A4 enzymes, hence drugs primarily metabolized by liver-3A4 enzymes are not likely to be affected by grapefruit juice (Fuhr, 1998; Menke, 1998). Following are selected examples of psychotropic agents known to have increased bioavailability when coadministered with grapefruit juice.

Anxiolytic Agents

Benzodiazepines. There have been contradictory reports on the interaction between grapefruit juice and benzodiazepines. Ozdemir, Aktan, Boydag, Cingi, and Musmul (1998) reported serum levels of diazepam (Valium) increased threefold when given with grapefruit juice. Other studies suggest increases in blood levels of triazolam (Halcion) and midazolam (Versed) when given with this juice (Fuhr, 1998; Hukkinen, Varhe, Olkkola, & Neuvonen, 1995). Kupferschmidt, Ha, Ziegler, Meier, and Krahenbuhl (1995) gave subjects oral or IV midazolam with water or grapefruit juice. Only those drinking grapefruit juice and receiving the drug orally had increased blood levels (-50%). The fact that IV midazolam did not increase in serum concentrations conforms with the information presented above that grapefruit juice only inhibits gut wall 3A4. Of course, IV midazolam would not experience a first-pass reduction. Grapefruit juice does not seem to affect alprazolam levels, and this may be related to its greater bioavailability and subsequent liver metabolism.

Buspirone. Buspirone (BuSpar) is a nonbenzodiazepine antianxiety drug with extensive first pass metabolism by P450-3A4. As little as 1% of buspirone reaches systemic circulation. When coadministered with "double-strength" grapefruit juice, buspirone has a concentration that is quadrupled (Lilja, Kivisto, Backman, Lamberg, & Neuvonen, 1998). Such dramatic increases could result in toxic levels of buspirone, leading to central nervous system effects. In such situations, advantages that buspirone has over benzodiazepines are compromised.

Antidepressants

Sertraline. Sertraline (Zoloft) is metabolized by P4503A4 and undergoes extensive first-pass metabolism (Keltner & Folks, 2001). One study reported a 50% increase in sertraline bioavailability when given with grapefruit juice (Lee, Chan, Harralson, Buffum, & Bui, 1999).

Tricylic antidepressants. Tricyclic antidepressants (TCAs) are metabolized by both 3A4 and 1A2. Amitriptyline (Elavil) and clomipramine (Anafranil), when given with grapefruit juice, have increased bioavailability (Vandel et al., 1999). Oesterheld and Kallepalli (1997) found that co-administration of grapefruit juice and clomimpramine increased clomipramine levels. Interestingly, the increase had a therapeutic effect on two children with obsessive compulsive disorder. Since TCAs are known to have a narrow therapeutic index, these are potentially important interactions.

Anticonvulsants

Carbamazepine. Carbamazepine (Tegretol) is an anticonvulsant often used in psychiatry for treatment of bipolar disorder and bipolar depression Recent research indicates mixing grapefruit juice and carbamazepine leads to a 40% increase in serum bioavailability of the anticonvulsant (Garg, Kumar, Bhargava, & Prabhakar, 1998). Since carbamazepine also has a narrow therapeutic index, this specific combination should be avoided to prevent a toxic state.

Condusion

Prescribing, administering, monitoring, and taking psychotropic drugs are serious endeavors. Knowledge about these agents is increasing rapidly-so rapidly that most of us cannot keep up. This article highlights one more potentially serious variable in the medication management of psychiatric patients. For your patients who are grapefruit juice lovers, this article is not good news. Obviously, more research needs to be conducted in this area. In the meantime, it is probably wise to recommend orange juice to these patients.

References

Bailey, D.G., MalcoLm, J., Arnold, O., & Spence, J.D. (1998). Grapefruit juice-drug interactions. British Journal of Clinical Pharmacology, 46, 101-110.

Cozza, K.L., & Armstrong, S.C. (2001). The cytochrome P450 system. Washington, DC: American Psychiatric Press.

Fuhr, U. (1998). Drug interactions with grapefruit juice. Extent, probable mechanism and clinical relevance. Drug Safety, 45, 355-359.

Fuhr, U., & Kummert, A.L. (1995). The fate of naringin in humans: A key to grapefruit juice-drug interactions? Clinical Pharmacology and Therapeutics, 58, 365-373.

Fukuda, K., Guo, L., Ohasi, N., Yoshikawa, M., & Yamazoe, Y. (2000). Amounts and variation in grapefruit juice of the main components causing grapefruit-drug interactions. Journal of Chromatography. Biomedical Sciences and Applications, 741, 195-203.

Garg, S.K., Kumar, N., Bhargava, V.K., & Prabhakar, S.K. (1998). Effects of grapefruit juice on carbamazepine bioavailability in patients with epilepsy. Clinical Pharmacology and Therapeutics, 64, 286-288.

Guengerich, F.P. (1997). Role of cytochrome P450 in drug-drug interactions. Advances in Pharmacology, 43, 7-35.

Hukkinen, S.K., Varhe, A., Olkkola, KT., & Neuvonen, PJ. (1995). Plasma concentrations of triazolam are increased by concomitant ingestion of grapefruit juice. Clinical Pharmacology and Therapeutics, 58,127-131.

Keltner, N.L., & Folks, D.G. (2001). Psychotropic drugs Ord ed.). St. Louis: Mosby.

Kupferschmidt, H.H., Ha, H.R., Ziegler, W.H., Meier, PJ., & Krahenbuhl, S. (1995). Interaction between grapefruit juice and midazolam in humans. Clinical Pharmacology and Therapeutics, 58,20-28.

Lee, AJ., Chan, W.K., Harralson, A.F., Buffum, J., & Bui, B.C. (1999). The effects of grapefruit juice on sertraline metabolism: An in vivo study. Clinical Therapeutics, 22,1890-1899.

Lehne, RA. (2001). Pharmacology for nursing care. Philadelphia: Saunders. Lilja, JJ., Kivisto, KT., Backman, J.T., Lamberg, T.S, & Neuvonen, P.J. (1998). Grapefruit juice substantially increases plasma concentrations of buspirone. Clinical Pharmacology and Therapeutics, 64, 655-660.

Malhotra, S., Bailey, D.G., Paine, M.F., & Watkins, P.B. (2001). Seville orange juice-felodipine interaction: Comparison with dilute grapefruit juice involvement of furocoumarins. Clinical Pharmacology and Therapeutics, 69,14-23.

Menke, J. (1998). Grapefruit juice: The untold story. South Dakota Medical Journal, 51, 421-422.

Oesterheld, J., & Kallepalli, B.R. (1997). Grapefruit juice and clomipramine: Shifting metabolic ratios. Journal of Clinical Psychopharmacology, 17, 62-63.

Ozdemir, M., Aktan, Y., Boydag, B.S., Cingi, M.I., & Musmul, A. (1998). Interaction between grapefruit juice and diazepam in humans. European Journal of Metabolism and Pharmacokinetics, 23, 55-59.

Vandel, P., Regina, W., Reix, I., Vande, S., Sechter, D., & Bizouard, P. (1999). Grapefruit juice as a contraindication? An approach in psychiatry. Encephale, 25, 67-71.

Search terms: Anticonvulsants, antidepressants, anxiolytics, drug interactions

Norman L. Keltner, EdD, RN, and Ifeoma Opara, BSN, RN

Norman L. Keltner, EdD, RN

Professor, University of Alabama, Birmingham, AL

Ifeoma Opara, BSN, RN

Staff Nurse, Brookwood Hospital, Birmingham, AL

Author contact: keltner@son.uab.edu, with a copy to the Editor: mary77@concentric.net

Copyright Nursecom, Inc. Jan-Mar 2002
Provided by ProQuest Information and Learning Company. All rights Reserved

Return to Anafranil
Home Contact Resources Exchange Links ebay